Phase 2 Nilotinib Trials for Parkinson's ... - Cure Parkinson's
Phase 2 Nilotinib Trials for Parkinson's Yield Conflicting Efficacy Results
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
The peer review comments are not flattering.
The allegedly successful trial showed improvement in biomarkers but not actual symptoms. The biomarker improvement was questioned. The participants in the test arm had more adverse effects in the control arm.
Not what you're looking for?
You may also like...
First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's
including speed of movement and coordination.
https://parkinsonsnewstoday.com/news/first-early-stag
Researchers link vascular defects to progression of Parkinson's disease. nilotinib may help
Has anyone seen this?And what do you think?
https://www.tangoherbs.com/2021/11/17/researchers-link-
Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS Trial
add-on Treatment in Patients Affected by ALS Trial https://clinicaltrials.gov/ct2/show/NCT03800524...
Anyone participating in the Buntanetap Phase 3 trial?
here:
https://clinicaltrials.gov/ct2/show/NCT05357989
Previously discussed on HU here:...
Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease (Nov 20, 2020)
the most recent paper on Nilotinib with you all....
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
Potential disease-modifying therapy enters Phase 2
Clinical trial suggests Parkinson's drug is safe in humans
Phase 3 Positive Topline Results for Tavapadon 
VieLight Trial Results
